SOX4 enhances tumor progression and cisplatin resistance in orthotopic mouse xenograft model of head and neck squamous cell carcinoma
These findings highlight the essential role of SOX4 in HNSCC progression and treatment resistance, suggesting SOX4 is a predictive biomarker and potential therapeutic target for improving treatment outcomes in patients with HNSCC.
Authors
- Yong Yeon Jeong (ORCID: https://orcid.org/0000-0001-6096-3130)
- Young‐Eun Joo (ORCID: https://orcid.org/0000-0003-0422-2439)
- Hye-Bin Jang
- Joon Kyoo Lee (ORCID: https://orcid.org/0000-0002-7542-9616)
- Sun‐Ae Kim (ORCID: https://orcid.org/0000-0002-6896-7459)
- Sang Chul Lim (ORCID: https://orcid.org/0000-0001-5610-1554)
- Eun Kyung Jung (ORCID: https://orcid.org/0000-0001-5371-3598)
- Kyung‐Hwa Lee (ORCID: https://orcid.org/0000-0002-3935-0361)
- Tae Mi Yoon (ORCID: https://orcid.org/0000-0002-6070-9113)
Institutions
- Chonnam National University Hwasun Hospital (KR)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1186/s12885-025-15024-9
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81